About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT00539214

Non-interventional Observational Study With Pramipexole: Impact on Non-motor Symptoms in Parkinson's Disease

* To compare the effect of pramipexole on depressive symptoms in early and advanced PD patients * To evaluate the course of depressive symptoms measured with UPDRS Part I (mentation, behavior and mood...

Lead sponsor: Boehringer Ingelheim•317 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Boehringer Ingelheim

Study Design:

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•1. Idiopathic Parkinsons disease with or without fluctuations
•2. Indication for treatment with Sifrol®
•3. Male or female patients of age
•4. Presence of at least mild depressive symptoms (as judged by the treating physician)
•5. Ability to reliably complete a self-rating scale (HADS)

Exclusion Criteria

•1. Any contraindications according to the Summary of Product Characteristics (SPC): hypersensitivity to pramipexole or to any of the excipients.
•2. Ongoing treatment with Sifrol®.

Related studies

Apathy in Parkinson Disease TMS Study

NCT06087926 · Parkinson Disease

Striatal and Extra-Striatal Cholinergic Terminal Density in LRRK2-PD Mutation

NCT07642908 · Parkinson Disease

RECRUITINGPhase 2

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

NCT06680830 · Parkinson Disease, Parkinson, and more

Cognitive Decline Following Deep Brain Stimulation

NCT05822388 · Parkinson Disease, Movement Disorders

Real-World Study of Foslevodopa/Foscarbidopa to Assess Quality of Life Outcomes in Adult Participants With Advanced Parkinson Disease

NCT06965374 · Parkinson Disease

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: November 1, 2013Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment1,192

Start dateMar 2007

Last updatedNov 1, 2013

Condition

Parkinson Disease

Locations shown

Boehringer Ingelheim

Aalen

Boehringer Ingelheim

Aarbergen

Boehringer Ingelheim

Adendorf

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 1, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions